Wednesday - August 19, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Tianjin Kilo Pharmaceutical Sci-tech
August 19, 2026
WASHINGTON, Aug. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Tianjin Kilo Pharmaceutical Sci-tech Co. Ltd. from its Center for Drug Evaluation and Research:

* * *

Recipient: Wenjun Liao, General Manager, Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd., Room 609, Building 6, no. 6 Ziyuan Road, Huayuan High-tech Industrial Park Tianjin Shi, 300384, China, (b)(4)

Issuing Office: Cent . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products